Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Anika Therapeutics (ANIK)

Anika Therapeutics (ANIK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 583,623
  • Shares Outstanding, K 14,207
  • Annual Sales, $ 105,560 K
  • Annual Income, $ 18,720 K
  • 60-Month Beta 1.08
  • Price/Sales 5.50
  • Price/Cash Flow 17.78
  • Price/Book 2.16

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 0.42
  • Number of Estimates 2
  • High Estimate 0.43
  • Low Estimate 0.40
  • Prior Year 0.68
  • Growth Rate Est. (year over year) -38.24%

Price Performance

See More
Period Period Low Period High Performance
1-Month
38.14 +6.50%
on 06/26/19
42.12 -3.55%
on 07/05/19
+0.61 (+1.52%)
since 06/19/19
3-Month
31.50 +28.95%
on 04/22/19
42.12 -3.55%
on 07/05/19
+8.98 (+28.38%)
since 04/18/19
52-Week
29.01 +40.02%
on 03/27/19
44.95 -9.63%
on 07/26/18
+6.50 (+19.05%)
since 07/19/18

Most Recent Stories

More News
Shares of ANIK Up 22.9% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Anika Therapeuti (NASDAQ:ANIK) on April 29th, 2019 at $33.16. In approximately 3 months, Anika Therapeuti has returned 22.95% as of today's recent price of $40.77.

ANIK : 40.62 (-1.12%)
Anika (ANIK) Moves to Buy: Rationale Behind the Upgrade

Anika (ANIK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

ANIK : 40.62 (-1.12%)
Global $7+ Bn Viscosupplementation Market 2019-2026 - Key Contributors are Sanofi, Anika Therapeutics, Seikagaku, Zimmer, Bioventus, Ferring, Lifecore Biomedical, and LG Life Sciences

The "Viscosupplementation Market Size, Share & Trends Analysis Report By Product (Single Injection, Three Injection, Five Injection), By Region, And Segment Forecasts, 2019 - 2026" report has been...

ANIK : 40.62 (-1.12%)
Anika to Exhibit its HA-Based Bone Repair Therapy at the 2019 American Orthopaedic Society for Sports Medicine Annual Meeting

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology, today...

ANIK : 40.62 (-1.12%)
Anika to Issue Second-Quarter 2019 Financial Results and Business Highlights on Wednesday, July 24

Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its second-quarter 2019 financial results after the close of the market on Wednesday, July 24, 2019 and hold its...

ANIK : 40.62 (-1.12%)
The Report Focuses On Medical Aesthetics Market development in the United States, Europe, Asia, Japan, and China…

VRX.TO : 30.80 (-3.33%)
ANIK : 40.62 (-1.12%)
HOLX : 48.27 (-0.47%)
AGN : 163.16 (+0.68%)
SIEN : 5.88 (-4.70%)
ELOS : 11.00 (unch)
Anika Therapeuti Has Returned 23.5% Since SmarTrend Recommendation (ANIK)

SmarTrend identified an Uptrend for Anika Therapeuti (NASDAQ:ANIK) on April 29th, 2019 at $33.16. In approximately 2 months, Anika Therapeuti has returned 23.52% as of today's recent price of $40.96.

ANIK : 40.62 (-1.12%)
Anika Appoints James Loerop as Executive Vice President of Business Development and Strategic Planning

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology, today...

ANIK : 40.62 (-1.12%)
Novavax (NVAX) Seeks Accelerated Approval Pathway for NanoFlu

Novavax (NVAX) seeks to use accelerated approval pathway for its influenza vaccine candidate, NanoFlu, in the United States.

ANIK : 40.62 (-1.12%)
AGTC : 3.88 (unch)
NVAX : 4.61 (-0.65%)
SNY : 41.95 (unch)
Anika Therapeuti Shares Up 18.9% Since SmarTrend's Buy Recommendation (ANIK)

SmarTrend identified an Uptrend for Anika Therapeuti (NASDAQ:ANIK) on April 29th, 2019 at $33.16. In approximately 2 months, Anika Therapeuti has returned 18.91% as of today's recent price of $39.43.

ANIK : 40.62 (-1.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong.

See More Share

Trade ANIK with:

Business Summary

Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative...

See More

Key Turning Points

2nd Resistance Point 41.75
1st Resistance Point 41.19
Last Price 40.62
1st Support Level 40.32
2nd Support Level 40.01

See More

52-Week High 44.95
Last Price 40.62
Fibonacci 61.8% 38.86
Fibonacci 50% 36.98
Fibonacci 38.2% 35.10
52-Week Low 29.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar